2020 意见书:重症患者抗菌药物治疗监测

2020-05-07 欧洲危重病医学会 Intensive Care Medicine.07 May 2020.

目前,各医疗机构在TDM的抗菌药物品种、患者群体、采样时间点和浓度监测的分析方法、PK/PD靶目标、剂量调整方法等方面有着显着差异。本文旨在回顾和讨论重症成年患者抗菌药物、抗真菌药物和抗病毒药物的TD

中文标题:

2020 意见书:重症患者抗菌药物治疗监测

英文标题:

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper

发布机构:

欧洲危重病医学会

发布日期:

2020-05-07

简要介绍:

目前,各医疗机构在TDM的抗菌药物品种、患者群体、采样时间点和浓度监测的分析方法、PK/PD靶目标、剂量调整方法等方面有着显着差异。本文旨在回顾和讨论重症成年患者抗菌药物、抗真菌药物和抗病毒药物的TDM可用数据。还将提供有关如何在日常临床实践中应用抗菌药物TDM改善重症成年患者治疗效果的实用指南。最后,专家小组旨在推荐哪些抗菌药物在重症患者中应常规进行TDM。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 意见书:重症患者抗菌药物治疗监测.pdf)] GetToolGuiderByIdResponse(projectId=1, id=cd3f61c0019032e8, title=2020 意见书:重症患者抗菌药物治疗监测, enTitle=Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper, guiderFrom=Intensive Care Medicine.07 May 2020., authorId=0, author=, summary=目前,各医疗机构在TDM的抗菌药物品种、患者群体、采样时间点和浓度监测的分析方法、PK/PD靶目标、剂量调整方法等方面有着显着差异。本文旨在回顾和讨论重症成年患者抗菌药物、抗真菌药物和抗病毒药物的TD, cover=https://img.medsci.cn/2020511/1589212028533_2020535.jpg, journalId=0, articlesId=null, associationId=746, associationName=欧洲危重病医学会, associationIntro=欧洲危重病医学会于1982年在瑞士日内日瓦成立,是一个非营利性的国际联盟组织。主要致力于支持和推进重症监护医学知识的更新和进步。, copyright=0, guiderPublishedTime=Thu May 07 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>目前,各医疗机构在TDM的抗菌药物品种、患者群体、采样时间点和浓度监测的分析方法、PK/PD靶目标、剂量调整方法等方面有着显着差异。本文旨在回顾和讨论重症成年患者抗菌药物、抗真菌药物和抗病毒药物的TDM可用数据。还将提供有关如何在日常临床实践中应用抗菌药物TDM改善重症成年患者治疗效果的实用指南。最后,专家小组旨在推荐哪些抗菌药物在重症患者中应常规进行TDM。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=5642, tagName=抗菌药物), TagDto(tagId=14375, tagName=危重症患者)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=38, categoryName=急重症科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=5642, guiderKeyword=抗菌药物, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4249, appHits=307, showAppHits=49, pcHits=1181, showPcHits=4087, likes=2, shares=12, comments=14, approvalStatus=1, publishedTime=Mon May 11 23:57:57 CST 2020, publishedTimeString=2020-05-07, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon May 11 23:47:19 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 22:13:57 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 意见书:重症患者抗菌药物治疗监测.pdf)])
2020 意见书:重症患者抗菌药物治疗监测.pdf
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1207130, encodeId=ec30120e13059, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Wed Mar 30 09:46:08 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968800, encodeId=eb9f9688007f, content=常学常新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/b0459812db6d4879a16a9ad584f56f61/74f39c08102b4bd3963434ecd8c6f84a.jpg, createdBy=7f3a3033698, createdName=icuwangwei, createdTime=Thu May 27 06:22:40 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961438, encodeId=c99c96143835, content=怎么得积分啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cd25438076, createdName=何帅, createdTime=Thu Apr 29 08:30:16 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961437, encodeId=0e0b96143e05, content=木有积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cd25438076, createdName=何帅, createdTime=Thu Apr 29 08:29:48 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916505, encodeId=3cf5916505e7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL6WtEGIUW7S4y7deE788VzMsq6otNLXEGN9TMqNva75ExPoZsyIlpZibuHYALoBYWED7lY6oUE3UQ/132, createdBy=14875307258, createdName=margery, createdTime=Thu Jan 14 14:02:32 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2022-03-30 洁巴子

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1207130, encodeId=ec30120e13059, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Wed Mar 30 09:46:08 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968800, encodeId=eb9f9688007f, content=常学常新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/b0459812db6d4879a16a9ad584f56f61/74f39c08102b4bd3963434ecd8c6f84a.jpg, createdBy=7f3a3033698, createdName=icuwangwei, createdTime=Thu May 27 06:22:40 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961438, encodeId=c99c96143835, content=怎么得积分啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cd25438076, createdName=何帅, createdTime=Thu Apr 29 08:30:16 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961437, encodeId=0e0b96143e05, content=木有积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cd25438076, createdName=何帅, createdTime=Thu Apr 29 08:29:48 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916505, encodeId=3cf5916505e7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL6WtEGIUW7S4y7deE788VzMsq6otNLXEGN9TMqNva75ExPoZsyIlpZibuHYALoBYWED7lY6oUE3UQ/132, createdBy=14875307258, createdName=margery, createdTime=Thu Jan 14 14:02:32 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-05-27 icuwangwei

    常学常新

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1207130, encodeId=ec30120e13059, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Wed Mar 30 09:46:08 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968800, encodeId=eb9f9688007f, content=常学常新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/b0459812db6d4879a16a9ad584f56f61/74f39c08102b4bd3963434ecd8c6f84a.jpg, createdBy=7f3a3033698, createdName=icuwangwei, createdTime=Thu May 27 06:22:40 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961438, encodeId=c99c96143835, content=怎么得积分啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cd25438076, createdName=何帅, createdTime=Thu Apr 29 08:30:16 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961437, encodeId=0e0b96143e05, content=木有积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cd25438076, createdName=何帅, createdTime=Thu Apr 29 08:29:48 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916505, encodeId=3cf5916505e7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL6WtEGIUW7S4y7deE788VzMsq6otNLXEGN9TMqNva75ExPoZsyIlpZibuHYALoBYWED7lY6oUE3UQ/132, createdBy=14875307258, createdName=margery, createdTime=Thu Jan 14 14:02:32 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-04-29 何帅

    怎么得积分啊

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1207130, encodeId=ec30120e13059, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Wed Mar 30 09:46:08 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968800, encodeId=eb9f9688007f, content=常学常新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/b0459812db6d4879a16a9ad584f56f61/74f39c08102b4bd3963434ecd8c6f84a.jpg, createdBy=7f3a3033698, createdName=icuwangwei, createdTime=Thu May 27 06:22:40 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961438, encodeId=c99c96143835, content=怎么得积分啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cd25438076, createdName=何帅, createdTime=Thu Apr 29 08:30:16 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961437, encodeId=0e0b96143e05, content=木有积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cd25438076, createdName=何帅, createdTime=Thu Apr 29 08:29:48 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916505, encodeId=3cf5916505e7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL6WtEGIUW7S4y7deE788VzMsq6otNLXEGN9TMqNva75ExPoZsyIlpZibuHYALoBYWED7lY6oUE3UQ/132, createdBy=14875307258, createdName=margery, createdTime=Thu Jan 14 14:02:32 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-04-29 何帅

    木有积分

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1207130, encodeId=ec30120e13059, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Wed Mar 30 09:46:08 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968800, encodeId=eb9f9688007f, content=常学常新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210526/b0459812db6d4879a16a9ad584f56f61/74f39c08102b4bd3963434ecd8c6f84a.jpg, createdBy=7f3a3033698, createdName=icuwangwei, createdTime=Thu May 27 06:22:40 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961438, encodeId=c99c96143835, content=怎么得积分啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cd25438076, createdName=何帅, createdTime=Thu Apr 29 08:30:16 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961437, encodeId=0e0b96143e05, content=木有积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cd25438076, createdName=何帅, createdTime=Thu Apr 29 08:29:48 CST 2021, time=2021-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916505, encodeId=3cf5916505e7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL6WtEGIUW7S4y7deE788VzMsq6otNLXEGN9TMqNva75ExPoZsyIlpZibuHYALoBYWED7lY6oUE3UQ/132, createdBy=14875307258, createdName=margery, createdTime=Thu Jan 14 14:02:32 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-01-14 margery

    学习

    0